63.40p-0.60 (-0.94 %)03 Dec 2020, 13:23
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Ekf Diagnostics Holdings PLC Fundamentals

Company NameEkf Diagnostics Holdings PLCLast Updated2020-12-03
IndustryDiagnostics & ResearchSectorHealthcare
Shares in Issue454.993 mMarket Cap£288.47 m
PE Ratio47.39Dividend per Share0
Dividend Yield1.53Dividend Cover0
EPS£0.01EPS Growth (%)-0.61
PEG0DPS Growth (%)0
Debt Ratio0.0152Debt Equity Ratio0.0145
Asset Equity Ratio1.3101Cash Equity Ratio0.2137
Quick Ratio1.3429Current Ratio1.74
Price To Book Value0ROCE0

Ekf Diagnostics Holdings PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Ekf Diagnostics Holdings PLC Company Financials

Tangible Assets£13.18 m£12.47 m£12.12 m
Intangible Assets£37.77 m£41.77 m£43.60 m
Investments£9.90 m£3.27 m£152,000.00
Total Fixed Assets£60.88 m£57.55 m£55.92 m
Stocks£6.07 m£6.12 m£5.64 m
Debtors£7.62 m£7.14 m£7.12 m
Cash & Equivalents£12.07 m£10.28 m£8.20 m
Other Assets000
Total Assets£87.13 m£81.38 m£77.16 m
Creditors within 1 year£12.86 m£13.60 m£12.30 m
Creditors after 1 year£3.10 m£3.87 m£4.36 m
Other Liabilities000
Total Liabilities£15.95 m£17.48 m£16.66 m
Net assets£71.17 m£63.90 m£60.50 m
Called up share capital£4.54 m£4.54 m£4.58 m
Share Premium000
Profit / Loss£5.52 m£12.16 m£4.31 m
Other Equity£70.57 m£63.53 m£59.97 m
Preference & Minorities£601,000.00£375,000.00£528,000.00
Total Capital Employed£71.17 m£63.90 m£60.50 m
Debt Ratio£0.01£0.01£0.01
Assets / Equity1.31011.31011.3101
Cash / Equity0.21370.21370.2137
Cash Flow201920182017
Cash from operating activities£5.10 m£8.32 m£9.05 m
Cashflow before financing£4.47 m£6.83 m£2.63 m
Increase in Cash£2.07 m£1.90 m£602,000.00
Turnover£44.92 m£42.54 m£41.58 m
Cost of sales£21.19 m£19.85 m£18.72 m
Gross Profit£23.73 m£22.70 m£22.86 m
Operating Profit£5.78 m£12.20 m£4.73 m
Pre-Tax profit£5.52 m£12.16 m£4.31 m

Ekf Diagnostics Holdings PLC Company Background

ActivitiesEKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company core business is point-of-care testing and to manufacture reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives most of its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.
Latest Interim Date14 Sep 2020
Latest Fiscal Year End Date7 Apr 2020

Ekf Diagnostics Holdings PLC Directors

2016-04-08Ron Zwanziger
2015-04-28Mr. Gordon James Hall
2020-05-25Mr. Christopher Harwood Bernard Mills Chairman
2015-11-20Dr. Kevin William Wilson
2020-05-25Mr. Adam Reynolds
2015-12-02Mr Paul Andrew Peter FoulgerFinance Director & Company Secretary
2020-05-25Mr. Julian Baines MBEChief Executive Officer
2017-04-18Mr. David Eric EvansDeputy Chairman
2015-12-30Dr Tito Bacarese-HamiltonChief Technology Officer
2011-08-09Anthony HutchinsonChief Executive
2020-05-25Mr. Richard Anthony Evans Finance Director & Chief Operating Officer
2017-04-18Salim HamirCompany Secretary

Ekf Diagnostics Holdings PLC Contact Details

Company NameEKF Diagnostics Holdings PLC
Address19 Stanwell Road, Penarth, Avon House, Cardiff, CF64 2EZ
Telephone+44 2920710570

Ekf Diagnostics Holdings PLC Advisors

Nominated AdviserN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
StockbrokerN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
AuditorPricewaterhouseCoopers LLP
Phone+44 2920237000
Fax+44 2920802400
RegistrarLink Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserWalbrook PR
Phone+44 2079338780
Fax+44 2079338781
SolicitorBerry Smith Solicitors
Phone(02920) 345 511
Fax(02920) 345 945